Abstract
Community acquired pneumonia (CAP) is among the leading causes of death worldwide. Despite intense research in the field and the development of new therapies, mortality remains largely unaltered for the past three decades. Antimicrobial agents are the cornerstone of therapy against CAP, but sometimes despite early diagnosis and the initiation of antibiotics, mortality remains high. A possible explanation may be due to several other host-related factors that keep the septic reaction intense. Part of this intensity may be attributed to the host-pathogen interaction and the deterioration of the host that is evoked by an immunologic overreaction. There is substantial evidence that macrolides have an inmunomodulatory effect on the host immune response, with multiple observational and prospective studies supporting a significant increased survival rate in patients with CAP treated with macrolides. We will review the significance of this non-antimicrobial effect of macrolides for the management of CAP.
Keywords: Community-acquired pneumonia, macrolides, immunomodulation, sepsis
Current Respiratory Medicine Reviews
Title: Macrolides in Community-Acquired Pneumonia: The Importance of the Non-Antimicrobial Effect
Volume: 6 Issue: 3
Author(s): Pedro J. Marcos, Grant W. Waterer, Nadia S. Brienza and Pedro Marcos-Velazquez
Affiliation:
Keywords: Community-acquired pneumonia, macrolides, immunomodulation, sepsis
Abstract: Community acquired pneumonia (CAP) is among the leading causes of death worldwide. Despite intense research in the field and the development of new therapies, mortality remains largely unaltered for the past three decades. Antimicrobial agents are the cornerstone of therapy against CAP, but sometimes despite early diagnosis and the initiation of antibiotics, mortality remains high. A possible explanation may be due to several other host-related factors that keep the septic reaction intense. Part of this intensity may be attributed to the host-pathogen interaction and the deterioration of the host that is evoked by an immunologic overreaction. There is substantial evidence that macrolides have an inmunomodulatory effect on the host immune response, with multiple observational and prospective studies supporting a significant increased survival rate in patients with CAP treated with macrolides. We will review the significance of this non-antimicrobial effect of macrolides for the management of CAP.
Export Options
About this article
Cite this article as:
J. Marcos Pedro, W. Waterer Grant, S. Brienza Nadia and Marcos-Velazquez Pedro, Macrolides in Community-Acquired Pneumonia: The Importance of the Non-Antimicrobial Effect, Current Respiratory Medicine Reviews 2010; 6 (3) . https://dx.doi.org/10.2174/157339810791526175
DOI https://dx.doi.org/10.2174/157339810791526175 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clinical Trials for Acute Kidney Injury: Design Challenges and Possible Solutions
Current Drug Targets Aliskiren: A Novel Renin Inhibitor for Hypertension
Current Drug Therapy HPLC-DAD-Q-TOF/MS-Based Screening and Analysis of the Multiple Absorbed Bioactive Components in Rat Serum after Oral Administration of Xiexin Tang
Current Pharmaceutical Analysis Treatment of Leukoaraiosis: A Futuristic View
Current Drug Targets The Concept of Titration can be Transposed to Fluid Management. But does is Change the Volumes? Randomised Trial on Pleth Variability Index During Fast-Track Colonic Surgery
Current Clinical Pharmacology Stevia as a Natural Sweetener: A Review
Cardiovascular & Hematological Agents in Medicinal Chemistry Towards the Development of Anticancer Drugs from Andrographolide: Semisynthesis, Bioevaluation, QSAR Analysis and Pharmacokinetic Studies
Current Topics in Medicinal Chemistry Natriuretic Peptide Family: New Aspects
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Neuropeptide Systems and Schizophrenia
CNS & Neurological Disorders - Drug Targets Mechanisms of Action of Hypertonic Saline Resuscitation in Severe Sepsis and Septic Shock
Endocrine, Metabolic & Immune Disorders - Drug Targets Microcirculation in Sepsis: New Perspectives
Current Vascular Pharmacology Cognitive Function and Heart Failure: The Role of the Adrenergic System
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Upper Airway Resistance Syndrome
Current Respiratory Medicine Reviews TNF alpha Inhibition as Treatment Modality for Certain Rheumatologic and Gastrointestinal Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Older and Newer Strategies for the Pharmacological Management of Agitation in Patients with Bipolar Disorder or Schizophrenia
CNS & Neurological Disorders - Drug Targets Pharmacological Therapy in Children with Atrial Fibrillation and Atrial Flutter
Current Pharmaceutical Design Antenatal Glucocorticoids Supplementation and Central Nervous System Development
Current Drug Metabolism Functional Roles of Benzothiazole Motif in Antiepileptic Drug Research
Mini-Reviews in Medicinal Chemistry Research Advances in Neuroblastoma Immunotherapy
Current Pediatric Reviews Ganoderma lucidum: A Potential for Biotechnological Production of Anti-Cancer and Immunomodulatory Drugs
Recent Patents on Anti-Cancer Drug Discovery